Skip to content

Anxiety: all studies

Page 265 of 769: studies 2,641 to 2,650 of 7,689, newest first. Back to the anxiety overview

Research

A systematic study of microdosing psychedelics

PLoS One February 6, 2019 Vince Polito, Richard J. Stevenson

The phenomenon of ‘microdosing’, that is, regular ingestion of very small quantities of psychedelic substances, has seen a rapid explosion of popularity in recent years. Individuals who microdose report minimal acute effects from these substances yet claim a range of long-term general health and wellbeing benefits. There have been no published empirical studies of microdosing and the current...

DOI: 10.1371/journal.pone.0211023 (opens in new tab) Anxiety Mood Expectancy theory Observational study +3

Acute behavioral effects of deliriant hallucinogens atropine and scopolamine in adult zebrafish.

Behavioural Brain Research February 1, 2019 Andrey D. Volgin, Oleg A. Yakovlev, Konstantin A. Demin et al.

Atropine and scopolamine are classical muscarinic cholinergic antagonists that exert multiple CNS effects. Belonging to a group of deliriant hallucinogens, these drugs induce delirium-like hallucinations, hyperactivity, altered affective states and amnesia. However, as deliriants remain the least studied group of hallucinogens, their complex and poorly understood profiles necessitate further...

Guided meditation as an adjunct to enhance postoperative recovery after cardiac surgery: study protocol for a prospective randomized controlled feasibility trial.

Trials January 11, 2019 Senthil Packiasabapathy, Ammu T Susheela, Ariel L Mueller et al.

Background: Cardiac surgical procedures are associated with postoperative neurological complications such as cognitive decline and delirium, which can complicate recovery and impair quality of life. Perioperative depression and anxiety may be associated with increased mortality after cardiac surgeries. Surgical prehabilitation is an emerging concept that includes preoperative interventions to...

The Experience of Racism on Behavioral Health Outcomes: The Moderating Impact of Mindfulness.

Mindfulness January 2019 Tamika C B Zapolski, Micah T Faidley, Marcy Beutlich

Research shows that racial discrimination results in adverse behavioral health outcomes for African American young adults, including risk for depression, anxiety, and substance use. Although high levels of mindfulness have been shown to reduce risk for such health outcomes, it is unknown whether mindfulness can reduce risk as a consequence of racial discrimination, particularly among African...

Efficacy of Internet-Delivered Mindfulness for Improving Depression in Caregivers of People With Spinal Cord Injuries and Chronic Neuropathic Pain: A Randomized Controlled Feasibility Trial.

Archives of Physical Medicine and Rehabilitation January 2019 Jasmine Heath Hearn, Imogen Cotter, Katherine Anne Finlay

To explore the feasibility and efficacy of web-based mindfulness training for carers of people with spinal cord injury (SCI). Randomized controlled feasibility study with 3-month follow-up. Community setting. Spouses or family caregivers (N=55) of people with SCI and chronic neuropathic pain were recruited via the direct care team and advertisements. Participants were older than 18 years (no...

Mindfulness-Based Interventions for Adults Living with HIV/AIDS: A Systematic Review and Meta-analysis.

AIDS and behavior 2019 Lori A J Scott-Sheldon, Brittany L Balletto, Marissa L Donahue et al.

This meta-analysis examined the effects of mindfulness-based interventions (MBIs) on stress, psychological symptoms, and biomarkers of disease among people living with HIV/AIDS (PLWHA). Comprehensive searches identified 16 studies that met the inclusion criteria (N = 1059; M age = 42 years; 20% women). Participants had been living with HIV for an average of 8 years (range = < 1-20 years); 65%...

The Effect of Mindfulness-Based Interventions on Tinnitus Distress. A Systematic Review.

Frontiers in Neurology 2019 Maaike M Rademaker, Inge Stegeman, Krysten E Ho-Kang-You et al.

Objectives: With this systematic review we aim to provide an overview of the evidence of the effect of Mindfulness Based Interventions (MBIs) on (1) tinnitus distress and (2) anxiety and/or depression in tinnitus patients. Methods: We conducted a systematic search in PubMed Medline, EMBASE and PsycInfo combining the terms and synonyms of "Tinnitus" and "Mindfulness." The most recent search was...

Ayahuasca's antidepressant effects covary with behavioral activation as well as mindfulness

2019 Maha N. Mian

Ayahuasca, a plant-based hallucinogen that serves as a spiritual medicine in South America, has improved depression in at least one placebo-controlled clinical trial. Case studies suggest that dramatic behavioral changes often follow the Ayahuasca ceremony, but most explanations of antidepressant effects focus on observed changes in mindfulness. The present study investigated if both...

My Dream, My Rules: Can Lucid Dreaming Treat Nightmares?

Frontiers in Psychology 2019 Tainá Carla Freitas De Macêdo, Glescikelly Herminia Ferreira, Katie Moraes De Almondes et al. 65 citations

Nightmares are defined as repeated occurrences of extremely dysphoric and well-remembered dreams that usually involve subjective threats to survival, security, or physical integrity. Generally, they occur during rapid eye movement sleep (REMS) and lead to awakenings with distress and insufficient overnight sleep. Nightmares may occur spontaneously (idiopathic) or as recurrent nightmares....

Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depression

Depression and Anxiety December 30, 2018 Naji C. Salloum, Maurizio Fava, Marlene P. Freeman et al. 49 citations

OBJECTIVE: To examine the effect of high baseline anxiety on response to ketamine versus midazolam (active placebo) in treatment-resistant depression (TRD). METHODS: In a multisite, double-blind, placebo-controlled trial, 99 subjects with TRD were randomized to one of five arms: a single dose of intravenous ketamine 0.1, 0.2, 0.5, 1.0 mg/kg, or midazolam 0.045 mg/kg. The primary outcome measure...